Age in years, median (range) |
7 (2, 15) |
7 (3, 17) |
0.69 |
Female, n (%) |
13 (54) |
18 (47) |
0.79 |
Any atopic disease, n (%) |
24 (100) |
36 (95) |
0.51 |
Bronchial asthma, n (%) |
11 (46) |
20 (53) |
0.79 |
Atopic dermatitis, n (%) |
17 (71) |
32 (84) |
0.22 |
Other food allergy, n (%) |
12 (50) |
21 (55) |
0.79 |
Allergic rhinitis, n (%) |
12 (50) |
26 (68) |
0.19 |
sIgE to storage protein (Ana o3/Ara h2) in kU/L, mean (range) |
4.2
(0.05, 36.9) |
40.2 (0.05, 120) |
<0.001 |
Reactive dose in the initial OFC in g nut protein, mean (range) |
0.576 (0.0084, 4.2) |
0.442 (0.0064, 3) |
0.77 |
Initial standard OFC, n (%) |
24 (100) |
20 (52) |
0.19 |
Reaction (oFass-5) |
|
|
|
Grade 1 |
1 (4) |
0 (0) |
|
Grade 2 |
12 (50) |
10 (50) |
|
Grade 3 |
9 (38) |
4 (20) |
|
Grade 4 |
2 (8) |
6 (30) |
|
Grade 5 |
0 (0) |
0 (0) |
|
Initial dose-escalation to 0.0064 g nut protein, n (%) |
0 (0) |
18
(47) |
|
Reaction (oFass-5) |
|
|
|
No Reaction |
0 |
15 (83) |
|
Grade 1 |
0 |
0 (0) |
|
Grade 2 |
0 |
2 (11) |
|
Grade 3 |
0 |
0 (0) |
|
Grade 4 |
0 |
1 (5) |
|
Grade 5 |
0 |
0 (0) |
|
Starting dose in g nut protein, mean (range) |
0.148 (0.001, 1.3) |
0.095 (0.0032, 1) |
0.044 |